Rosiglitazone ameliorates acute hepatic injury via activating the Nrf2 signaling pathway and inhibiting activation of the NLRP3 inflammasome

Ling Ma(Xinjiang Medical University), Ming Ma(People's Hospital of Xinjiang Uygur Autonomous Region)
Experimental and Therapeutic Medicine
February 21, 2022
Cited by 8


Related Papers